SCHEMBL13985124

SCHEMBL13985124

NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.56
SLC1A2 P43004 1/20 0.56
SLC1A1 P43005 1/20 0.56
BDKRB1 P46663 11/20 0.56
BDKRB2 P30411 2/20 0.56
EEF2K O00418 3/20 0.53
ALDH1A1 P00352 2/20 0.52
ATM Q13315 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C9 P11712 2/20 0.49
TSHR P16473 2/20 0.49
CYP2C19 P33261 2/20 0.49
MAPT P10636 1/20 0.49
PKM P14618 1/20 0.49
F2 P00734 1/20 0.49
PRSS1 P07477 1/20 0.49
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6652039 1.00 SLC1A3 (0.56) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2
SCHEMBL644240 0.90 EEF2K (0.66) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2
SCHEMBL3310158 0.90 EEF2K (0.66) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2
SCHEMBL13780961 0.85 CYP1A2 (0.55) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2
SCHEMBL2933326 0.85 CYP1A2 (0.55) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2
SCHEMBL26606040 0.83 SLC1A3 (0.61) SLC1A3SLC1A2SLC1A1ALDH1A1F2
SCHEMBL26606049 0.83 SLC1A3 (0.61) SLC1A3SLC1A2SLC1A1ALDH1A1F2
SCHEMBL12317324 0.82 GAA (0.56) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2
SCHEMBL6953103 0.81 EEF2K (0.56) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2
SCHEMBL3441384 0.81 BDKRB1 (0.51) SLC1A3SLC1A2SLC1A1BDKRB1BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008153967-A1 BK1 ANTAGONIST CONJUGATES CONTEC THERAPEUTICS, INC. (US) 2008-12-18 WO disclosed